Dragon Sail Pharmaceutical Co., Ltd. is a Chinese CDMO founded in 2016, focusing on antibody drug CDMO/CMO services from sequence to IND through commercial production. The company built China's first cross-free antibody plant in the Shanghai Lin-gang Special Area with a total investment of nearly RMB 700 million and a maximum production scale of 12,000L.
Antibody drugs, Monoclonal antibodies, Bispecific antibodies, Fusion proteins, ADC development, Cell line construction, NONCROS cross-free production
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.